Skip to main content
Top
Published in: Clinical and Experimental Nephrology 6/2011

01-12-2011 | Original Article

Validation of the equations for estimating daily sodium excretion from spot urine in patients with chronic kidney disease

Authors: Enyu Imai, Yoshinari Yasuda, Masaru Horio, Kanako Shibata, Sawako Kato, Yu Mizutani, Junko Imai, Mutsuharu Hayashi, Hideki Kamiya, Yutaka Oiso, Toyoaki Murohara, Shoichi Maruyama, Seiichi Matsuo

Published in: Clinical and Experimental Nephrology | Issue 6/2011

Login to get access

Abstract

Background

Measuring sodium excretion in a 24-h urine collection is the most reliable method of estimating salt intake, but it is not applicable to all patients. As an alternative, equations for estimating Na excretion from Japanese by a spot urine sample were created, but they have not been validated in patients with chronic kidney disease (CKD), which are frequently associated with nocturia and medication.

Methods

We enrolled 136 patients with CKD and collected both 24-h urine and the first morning urine. Na excretion was estimated from the first morning urine by Kawasaki’s equation, which was originally used for the second morning urine, and Tanaka’s equation, which is applied for spot urine samples taken at any time from 9 am to 7 pm. We evaluated the two equations for bias, RMSE and accuracy within 30 and 50% of the measured Na excretion.

Results

Bias, RMSE and accuracy within 30% of the estimated Na excretion were 48 ± 69 and 2 ± 69 mmol/day, 84 and 69 mmol/day, and 35 and 49% using Kawasaki’s equation and Tanaka’s equation, respectively. Na excretion in the first morning urine was accurately estimated by Tanaka’s equation, but it was overestimated by Kawasaki’s equation. Nocturia and medication such as diuretics and ACE inhibitor or angiotensin receptor blocker did not affect the accuracy with which Na excretion was estimated by Tanaka’s equation substantially.

Conclusion

Tanaka’s equation for estimating Na excretion from the first morning urine in patients with CKD is accurate enough for use in clinical practice.
Literature
1.
go back to reference Strazzullo P, D’Elia L, Kandala NB, Cappuccio FP. Salt intake, stroke, and cardiovascular disease: meta-analysis of prospective studies. BMJ. 2009;339:b4567.PubMedCrossRef Strazzullo P, D’Elia L, Kandala NB, Cappuccio FP. Salt intake, stroke, and cardiovascular disease: meta-analysis of prospective studies. BMJ. 2009;339:b4567.PubMedCrossRef
2.
go back to reference Cook NR, Cutler JA, Obarzanek E, Buring JE, Rexrode KM, Kumanyika SK, Appel LJ, Whelton PK. Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention (TOHP). BMJ. 2007;334(7599):885–8.PubMedCrossRef Cook NR, Cutler JA, Obarzanek E, Buring JE, Rexrode KM, Kumanyika SK, Appel LJ, Whelton PK. Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention (TOHP). BMJ. 2007;334(7599):885–8.PubMedCrossRef
3.
go back to reference Intersalt Cooperative Research Group. Intersalt: an international study of electrolyte excretion and blood pressure. Results for 24 hour urinary sodium and potassium excretion. BMJ. 1988;297(6644):319–28. Intersalt Cooperative Research Group. Intersalt: an international study of electrolyte excretion and blood pressure. Results for 24 hour urinary sodium and potassium excretion. BMJ. 1988;297(6644):319–28.
4.
go back to reference Hooper L, Bartlett C, Davey Smith G, Ebrahim S. Reduced dietary salt for prevention of cardiovascular disease. Cochrane Database Syst Rev. 2003;3:CD003656. Hooper L, Bartlett C, Davey Smith G, Ebrahim S. Reduced dietary salt for prevention of cardiovascular disease. Cochrane Database Syst Rev. 2003;3:CD003656.
5.
go back to reference Bibbins-Domingo K, Chertow GM, Coxson PG, Moran A, Lightwood JM, Pletcher MJ, Goldman L. Projected effect of dietary salt reductions on future cardiovascular disease. N Engl J Med. 2010;362(7):590–9.PubMedCrossRef Bibbins-Domingo K, Chertow GM, Coxson PG, Moran A, Lightwood JM, Pletcher MJ, Goldman L. Projected effect of dietary salt reductions on future cardiovascular disease. N Engl J Med. 2010;362(7):590–9.PubMedCrossRef
6.
go back to reference The Japanese Society of Hypertension. Guidelines (JSH 2009). Chapter 4: lifestyle modifications. Hypertens Res. 2009;32:29–32. The Japanese Society of Hypertension. Guidelines (JSH 2009). Chapter 4: lifestyle modifications. Hypertens Res. 2009;32:29–32.
7.
go back to reference Kawano Y, Tsuchihashi T, Matsuura H, Ando K, Fujita T, Ueshima H. Report of the Working Group for Dietary Salt Reduction of the Japanese Society of Hypertension. 2. Assessment of salt intake in the management of hypertension. Hypertens Res. 2007;30(10):887–93. Kawano Y, Tsuchihashi T, Matsuura H, Ando K, Fujita T, Ueshima H. Report of the Working Group for Dietary Salt Reduction of the Japanese Society of Hypertension. 2. Assessment of salt intake in the management of hypertension. Hypertens Res. 2007;30(10):887–93.
8.
go back to reference Kamata K, Tochikubo O. Estimation of 24-h urinary sodium excretion using lean body mass and overnight urine collected by a pipe-sampling method. J Hypertens. 2002;20(11):2191–7.PubMedCrossRef Kamata K, Tochikubo O. Estimation of 24-h urinary sodium excretion using lean body mass and overnight urine collected by a pipe-sampling method. J Hypertens. 2002;20(11):2191–7.PubMedCrossRef
9.
go back to reference Kawasaki T, Itoh K, Uezono K, Sasaki H. A simple method for estimating 24 h urinary sodium and potassium excretion from second morning voiding urine specimen in adults. Clin Exp Pharmacol Physiol. 1993;20(1):7–14.PubMedCrossRef Kawasaki T, Itoh K, Uezono K, Sasaki H. A simple method for estimating 24 h urinary sodium and potassium excretion from second morning voiding urine specimen in adults. Clin Exp Pharmacol Physiol. 1993;20(1):7–14.PubMedCrossRef
10.
go back to reference Kawasaki T, Itoh K, Uezono K, Ogaki T, Yoshimizu Y, Kobayashi S, Osaka T, Ogata M, Dhungel S, Sharma S, et al. Investigation of high salt intake in a Nepalese population with low blood pressure. J Hum Hypertens. 1993;7(2):131–40.PubMed Kawasaki T, Itoh K, Uezono K, Ogaki T, Yoshimizu Y, Kobayashi S, Osaka T, Ogata M, Dhungel S, Sharma S, et al. Investigation of high salt intake in a Nepalese population with low blood pressure. J Hum Hypertens. 1993;7(2):131–40.PubMed
11.
go back to reference Hashimoto T, Yagami F, Owada M, Sugawara T, Kawamura M. Salt preference according to a questionnaire vs. dietary salt intake estimated by a spot urine method in participants at a health check-up center. Intern Med. 2008;47(5):399–403.PubMedCrossRef Hashimoto T, Yagami F, Owada M, Sugawara T, Kawamura M. Salt preference according to a questionnaire vs. dietary salt intake estimated by a spot urine method in participants at a health check-up center. Intern Med. 2008;47(5):399–403.PubMedCrossRef
12.
go back to reference Iseki K, Iseki C, Itoh K, Uezono K, Sanefuji M, Ikemiya Y, Fukiyama K, Kawasaki T. Urinary excretion of sodium and potassium in a screened cohort in Okinawa, Japan. Hypertens Res. 2002;25(5):731–6.PubMedCrossRef Iseki K, Iseki C, Itoh K, Uezono K, Sanefuji M, Ikemiya Y, Fukiyama K, Kawasaki T. Urinary excretion of sodium and potassium in a screened cohort in Okinawa, Japan. Hypertens Res. 2002;25(5):731–6.PubMedCrossRef
13.
go back to reference Kawamura M, Kusano Y, Takahashi T, Owada M, Sugawara T. Effectiveness of a spot urine method in evaluating daily salt intake in hypertensive patients taking oral antihypertensive drugs. Hypertens Res. 2006;29(6):397–402.PubMedCrossRef Kawamura M, Kusano Y, Takahashi T, Owada M, Sugawara T. Effectiveness of a spot urine method in evaluating daily salt intake in hypertensive patients taking oral antihypertensive drugs. Hypertens Res. 2006;29(6):397–402.PubMedCrossRef
14.
go back to reference Tanaka T, Okamura T, Miura K, Kadowaki T, Ueshima H, Nakagawa H, Hashimoto T. A simple method to estimate populational 24-h urinary sodium and potassium excretion using a casual urine specimen. J Hum Hypertens. 2002;16(2):97–103.PubMedCrossRef Tanaka T, Okamura T, Miura K, Kadowaki T, Ueshima H, Nakagawa H, Hashimoto T. A simple method to estimate populational 24-h urinary sodium and potassium excretion using a casual urine specimen. J Hum Hypertens. 2002;16(2):97–103.PubMedCrossRef
15.
go back to reference Tamaki J, Kikuchi Y, Yoshita K, Takebayashi T, Chiba N, Tanaka T, Okamura T, Kasagi F, Minai J, Ueshima H. Stages of change for salt intake and urinary salt excretion: baseline results from the High-Risk and Population Strategy for Occupational Health Promotion (HIPOP-OHP) study. Hypertens Res. 2004;27(3):157–66.PubMedCrossRef Tamaki J, Kikuchi Y, Yoshita K, Takebayashi T, Chiba N, Tanaka T, Okamura T, Kasagi F, Minai J, Ueshima H. Stages of change for salt intake and urinary salt excretion: baseline results from the High-Risk and Population Strategy for Occupational Health Promotion (HIPOP-OHP) study. Hypertens Res. 2004;27(3):157–66.PubMedCrossRef
16.
go back to reference Fukuda M, Motokawa M, Miyagi S, Sengo K, Muramatsu W, Kato N, Usami T, Yoshida A, Kimura G. Polynocturia in chronic kidney disease is related to natriuresis rather than to water diuresis. Nephrol Dial Transplant. 2006;21:2172–7.PubMedCrossRef Fukuda M, Motokawa M, Miyagi S, Sengo K, Muramatsu W, Kato N, Usami T, Yoshida A, Kimura G. Polynocturia in chronic kidney disease is related to natriuresis rather than to water diuresis. Nephrol Dial Transplant. 2006;21:2172–7.PubMedCrossRef
17.
go back to reference Uzu T, Kimura G. Diuretics shift circadian rhythm of blood pressure from nondipper to dipper in essential hypertension. Circulation. 1999;100(15):1635–8.PubMedCrossRef Uzu T, Kimura G. Diuretics shift circadian rhythm of blood pressure from nondipper to dipper in essential hypertension. Circulation. 1999;100(15):1635–8.PubMedCrossRef
18.
go back to reference Fukuda M, Yamanaka T, Mizuno M, Motokawa M, Shirasawa Y, Miyagi S, Nishio T, Yoshida A, Kimura G. Angiotensin II type 1 receptor blocker, olmesartan, restores nocturnal blood pressure decline by enhancing daytime natriuresis. J Hypertens. 2008;26(3):583–8.PubMedCrossRef Fukuda M, Yamanaka T, Mizuno M, Motokawa M, Shirasawa Y, Miyagi S, Nishio T, Yoshida A, Kimura G. Angiotensin II type 1 receptor blocker, olmesartan, restores nocturnal blood pressure decline by enhancing daytime natriuresis. J Hypertens. 2008;26(3):583–8.PubMedCrossRef
19.
go back to reference Kawamura M, Hashimoto T, Owada M, Sugawara T. The influence of posture on the estimation of daily salt intake by the second morning urine method. Hypertens Res. 2010;33:505–10.PubMedCrossRef Kawamura M, Hashimoto T, Owada M, Sugawara T. The influence of posture on the estimation of daily salt intake by the second morning urine method. Hypertens Res. 2010;33:505–10.PubMedCrossRef
20.
go back to reference Ogihara T, Kikuchi K, Matsuoka H, Fujita T, Higaki J, Horiuchi M, Imai Y, Imaizumi T, Ito S, Iwao H, Kario K, Kawano Y, Kim-Mitsuyama S, Kimura G, Matsubara H, Matsuura H, Naruse M, Saito I, Shimada K, Shimamoto K, Suzuki H, Takishita S, Tanahashi N, Tsuchihashi T, Uchiyama M, Ueda S, Ueshima H, Umemura S, Ishimitsu T, Rakugi H. The Japanese Society of Hypertension guidelines for the management of hypertension (JSH 2009). Hypertens Res. 2009;32(1):3–107.PubMedCrossRef Ogihara T, Kikuchi K, Matsuoka H, Fujita T, Higaki J, Horiuchi M, Imai Y, Imaizumi T, Ito S, Iwao H, Kario K, Kawano Y, Kim-Mitsuyama S, Kimura G, Matsubara H, Matsuura H, Naruse M, Saito I, Shimada K, Shimamoto K, Suzuki H, Takishita S, Tanahashi N, Tsuchihashi T, Uchiyama M, Ueda S, Ueshima H, Umemura S, Ishimitsu T, Rakugi H. The Japanese Society of Hypertension guidelines for the management of hypertension (JSH 2009). Hypertens Res. 2009;32(1):3–107.PubMedCrossRef
21.
go back to reference Japanese Society of Nephrology. Evidence-based practice guideline for the treatment of CKD. Clin Exp Nephrol. 2009;13(6):537–66. Japanese Society of Nephrology. Evidence-based practice guideline for the treatment of CKD. Clin Exp Nephrol. 2009;13(6):537–66.
Metadata
Title
Validation of the equations for estimating daily sodium excretion from spot urine in patients with chronic kidney disease
Authors
Enyu Imai
Yoshinari Yasuda
Masaru Horio
Kanako Shibata
Sawako Kato
Yu Mizutani
Junko Imai
Mutsuharu Hayashi
Hideki Kamiya
Yutaka Oiso
Toyoaki Murohara
Shoichi Maruyama
Seiichi Matsuo
Publication date
01-12-2011
Publisher
Springer-Verlag
Published in
Clinical and Experimental Nephrology / Issue 6/2011
Print ISSN: 1342-1751
Electronic ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-011-0523-0

Other articles of this Issue 6/2011

Clinical and Experimental Nephrology 6/2011 Go to the issue

Acknowledgment

List of referees

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine